Endocrine System - Adrenal Glands, Pineal Gland, and Pancreas

Adrenal Glands

  • Located superior to each kidney, retroperitoneal.

  • Pyramid shaped and approximately 3 cm in height, 5 cm in length, and up to 1 cm thick.

  • Heavily vascularized.

  • Subdivided into:

    • Outer adrenal cortex:

      • Makes up 80-90% of the gland's total mass.

      • Stores lipids (cholesterol and fatty acids) used for hormone synthesis.

      • Manufactures more than 20 steroid hormones, collectively called corticosteroids, which are vital for regulating metabolic processes.

    • Inner adrenal medulla:

      • Makes up 10-20% of the adrenal gland.

      • Produces catecholamine hormones: epinephrine and norepinephrine.

      • Secretory activities are controlled by the sympathetic nervous system, preparing the body for "fight or flight".

      • Metabolic changes persist for several minutes, allowing for sustained response to stress.

Adrenal Cortex

  • Accounts for the bulk of the adrenal gland.

  • Produces hormones essential for life; damage to the adrenal cortex leads to deficiency in corticosteroids.

  • Subdivided into three distinct regions, each producing different corticosteroids:

    • Zona glomerulosa

    • Zona fasciculata

    • Zona reticularis

Zona Glomerulosa

  • The thin, outer region of the adrenal cortex, directly under the capsule.

  • Produces mineralocorticoids, primarily aldosterone, which regulates blood pressure and electrolyte balance.

Zona Fasciculata

  • The thick, middle region of the adrenal cortex that consists of cells arranged in columns.

  • Produces glucocorticoids, mainly cortisol (hydrocortisone), in response to ACTH from the pituitary gland.

  • Glucocorticoids influence glucose metabolism and have anti-inflammatory effects.

  • Have an inhibitory effect on the production of:

    • Corticotropin-releasing hormone (CRH) in the hypothalamus, providing negative feedback.

    • ACTH in the anterior pituitary, also contributing to negative feedback.

Glucocorticoids

  • Affect glucose metabolism, immune response, and stress response.

  • Adipose tissue breaks down triglycerides (lipid catabolism) to provide energy.

  • Skeletal muscle breaks down proteins (protein catabolism), releasing amino acids.

  • Cells utilize fatty acids and amino acids for energy instead of glucose, conserving glucose for the brain.

  • Accelerates glucose synthesis (Gluconeogenesis) in the liver.

  • Considered a stress hormone due to its role in the body’s response to stressful situations.

  • Show anti-inflammatory effects by reducing immune cell activity.

  • Suppress the immune system, which can be therapeutically useful but also increases susceptibility to infection.

Zona Reticularis

  • The innermost region of the adrenal cortex, adjacent to the adrenal medulla.

  • Produces androgens (sex hormones) under stimulation by ACTH.

  • Androgen production is insignificant in males, as the testes produce much larger amounts.

  • In females, it promotes muscle mass, blood cell formation, and sex drive but can also contribute to masculinization if overproduced.

Adrenal Medulla

  • The central part of the adrenal gland, surrounded by the adrenal cortex.

  • A neuroendocrine structure innervated by sympathetic preganglionic fibers.

  • Produces catecholamines: Epinephrine (Epi) and Norepinephrine (Norepi), which are involved in the "fight or flight" response.

  • In muscle and liver, they trigger the breakdown of glycogen into glucose (glycogenolysis), providing quick energy.

  • In the liver, new glucose molecules are synthesized (gluconeogenesis).

  • In adipose tissue, triglycerides (TG) are broken down into free fatty acids (FFA).

  • Fatty acids are released into the bloodstream and used by other tissues for ATP production, sparing glucose for the brain (Glucose Sparing Effect).

  • In the heart, they increase heart rate and force of contraction to enhance blood flow.

Effects of Epinephrine and Norepinephrine

  • Increased heart rate, force of contraction, and blood pressure (BP) to enhance oxygen delivery to tissues.

  • Lipid breakdown and release, providing alternative energy sources.

  • Glycogen breakdown to increase blood glucose levels.

  • Increased glucose synthesis to maintain blood glucose levels during stress.

Pineal Gland

  • A small endocrine gland in the brain.

  • Attached to the roof of the third ventricle.

  • Contains pinealocytes that synthesize the hormone melatonin.

  • Collaterals from visual pathways enter the pineal gland and affect pinealocyte activity, synchronizing melatonin production with light-dark cycles.

  • Melatonin production is lowest during daylight hours and highest during nighttime hours, influencing sleep patterns.

Functions of Melatonin

  • Regulates sleep-wake cycles (circadian rhythms).

  • May be involved in preventing sexual maturation until puberty.

  • The pineal gland shrinks and melatonin production declines greatly by the end of puberty.

  • Pineal tumors can cause premature onset of puberty, demonstrating the hormone's role in sexual development.

  • Influences circadian rhythms (sleep cycles), affecting mood, behavior, and reproductive physiology.

Pancreas

  • A mixed gland with both exocrine and endocrine functions.

  • Lies along the inferior border of the stomach, between the first segment of the small intestine and the spleen.

  • Contains exocrine and endocrine cells arranged in distinct regions.

  • Exocrine portion:

    • Takes up 99% of the pancreas.

    • Consists of acinar cells that secrete digestive enzymes.

    • Secretes an alkaline, enzyme-rich fluid into the digestive tract to aid digestion.

Endocrine Pancreas

  • Consists of cells that form clusters known as pancreatic islets, or islets of Langerhans.

    • Alpha cells produce glucagon in response to low blood glucose, raising blood glucose levels.

    • Beta cells produce insulin in response to high blood glucose, lowering blood glucose levels.

    • Delta cells produce somatostatin, a peptide hormone identical to GH–IH (Growth Hormone–Inhibiting Hormone), inhibiting both insulin and glucagon secretion.

    • F cells / PP Cells secrete pancreatic polypeptide (PP), which regulates pancreatic exocrine and endocrine secretions.

Pancreas: Blood Glucose Control

  • Maintains glucose homeostasis by controlling blood glucose levels via the secretion of insulin and glucagon.

  • When glucose levels rise (hyperglycemia):

    • Beta cells secrete insulin, stimulating:

      • Transport of glucose into cells to lower blood glucose levels.

      • Increased glucose use (to make ATP) for energy production.

      • Increased conversion of glucose to glycogen for storage in the liver and muscles.

      • Increased amino acid uptake and utilization (to make proteins) for growth and repair.

      • Increased synthesis of triglycerides in adipose tissue for long-term energy storage.

  • When glucose levels decline (hypoglycemia):

    • Alpha cells release glucagon, stimulating:

      • Breakdown of glycogen into glucose in skeletal muscle and liver to raise blood glucose levels.

      • Breakdown of triglycerides into fatty acids in adipose tissue to provide alternative fuel sources.

      • Gluconeogenesis in the liver, synthesizing glucose from amino acids and other precursors.

      • Synthesis of glucose from amino acids when glycogen stores are depleted.

Effects of Insulin

  • Increased rate of glucose transport into target cells, especially muscle and adipose tissue.

  • Increased rate of glucose utilization and ATP generation, promoting energy production.

  • Increased conversion of glucose to glycogen, storing glucose for later use.

  • Increased amino acid absorption and protein synthesis, supporting growth and repair processes.

  • Increased triglyceride synthesis in adipose tissue, storing excess energy as fat.

Effects of Glucagon

  • Increased breakdown of glycogen to glucose (in liver, skeletal muscle), raising blood glucose levels.

  • Increased breakdown of fat to fatty acids (in adipose tissue), providing alternative fuel sources.

  • Increased synthesis and release of glucose (by the liver) through gluconeogenesis, maintaining blood glucose levels.

Diabetes Mellitus

  • A group of metabolic disorders characterized by hyperglycemia over a prolonged period.

  • Characterized by glucose concentrations high enough to overwhelm the reabsorption capabilities of the kidneys, leading to glucosuria.

  • Hyperglycemia = abnormally high glucose levels in the blood due to defects in insulin secretion, insulin action, or both.

  • In DM, glucose appears in the urine (glucosuria), and urine volume generally becomes excessive (polyuria) due to the osmotic effect of glucose.

Type 1 Diabetes Mellitus

  • (Insulin dependent), formerly known as juvenile diabetes.

  • Characterized by inadequate insulin production by beta cells, leading to absolute insulin deficiency.

  • Patients require exogenous insulin to survive and usually require multiple injections daily or continuous infusion through an insulin pump or other device.

  • This form of diabetes accounts for only around 5%–10% of cases.

  • Often develops in childhood or adolescence but can occur at any age.

  • May be associated with autoimmune destruction of beta cells, triggered by genetic or environmental factors.

  • Obesity is usually not present at diagnosis.

Type 2 Diabetes Mellitus

  • (Non-insulin dependent), formerly known as adult-onset diabetes.

  • Is the most common form of diabetes mellitus, accounting for 90-95% of cases.

  • Most people with this form of diabetes produce normal or even elevated amounts of insulin, at least initially, but their tissues do not respond properly, a condition known as insulin resistance.

  • Insulin resistance is often associated with obesity, physical inactivity, and genetic factors.

  • Type 2 diabetes is strongly associated with obesity and is becoming increasingly prevalent in younger populations.

  • Weight loss through diet and exercise can improve insulin sensitivity and be an effective treatment.

Complications of Untreated or Poorly Managed Diabetes Mellitus

  • Chronic hyperglycemia leads to various microvascular and macrovascular complications.

  • Kidney damage (diabetic nephropathy) leading to renal failure and the need for dialysis or kidney transplant.

  • Retinal damage (diabetic retinopathy) leading to blindness or significant vision impairment.

  • Early heart attacks and stroke (cardiovascular disease) due to accelerated atherosclerosis.

  • Peripheral nerve damage (diabetic neuropathy) leading to pain, numbness, and increased risk of foot ulcers.

  • Poor circulation combined with slow wound healing and numbness lead to frequent amputations due to diabetic foot ulcers and infections.